HOME >> BIOLOGY >> NEWS
Nanoparticles carry chemotherapy drug deeper into solid tumors

A new drug delivery method using nano-sized molecules to carry the chemotherapy drug doxorubicin to tumors improves the effectiveness of the drug in mice and increases their survival time, according to a study published online June 26 in the Journal of the National Cancer Institute.

In the past, similar drug carriers have improved targeted delivery of the drugs and reduced toxicity, but they sometimes decreased the drugs ability to kill the tumor cells. Using a new drug carrier, Ning Tang of the Chinese Academy of Sciences in Beijing and colleagues compared tumor growth and survival in mice that were given doxorubicin in the nanocarriers or on its own.

Doxorubicin delivered by nanocarriers was more effective in preventing tumor growth than free doxorubicin, and the mice receiving this treatment method lived longer and had fewer toxic side effects.

Encapsulation of doxorubicinincreased its accumulation and penetration in tumors in terms of both the percentage of cells that were reached by the drug and the intracellular levels that were attained, the authors write.

In an accompanying editorial, Matthew Dreher, Ph.D., of the National Institutes of Health in Bethesda, Md., and Ashutosh Chilkoti, Ph.D., of Duke University in Durham, N.C., discuss the future of drug delivery, which they think should focus on three important research areasdrug combinations, targeting, and integration.

The study by Tang [and colleagues] is a simple but effective demonstration of the benefits of integration of a drug with an appropriate carrier to yield a striking gain in efficacy, the authors write. May the days of pharmacological missiles that miss their target and friendly fire that kills patients soon be over!


'"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
26-Jun-2007


Page: 1

Related biology news :

1. Nanoparticles hitchhike on red blood cells: a potential new method for drug delivery
2. Cancer tip -- Nanoparticles can damage DNA, increase cancer risk
3. Little lifesavers -- Nanoparticles improve delivery of medicines and diagnostics
4. Nanoparticles for delivery of prostate cancer treatment
5. MIT, Brigham: Nanoparticles armed to combat cancer
6. Nanoparticles create biocompatible capsules
7. Nanoparticles, nanoshells, nanotubes: How tiny specks may provide powerful tools against cancer
8. New model for autism suggests women carry the disorder and explains age as a risk factor
9. New highways carry pathogens and social change in Ecuador
10. Non-steroidal anti-inflammatory drug increases liver damage in mice carrying mutant human gene
11. Neural stem cells derived from human embryonic stem cells carry abnormal gene expression

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/13/2020)... ... June 11, 2020 , ... Bode Technology ... of its forensic genealogy team. Bode’s Forensic Genealogy Service (FGS) continues ... and DNA analysis methods. The team has added experienced genealogists, each having over ...
(Date:6/11/2020)... ... June 09, 2020 , ... Superior Controls, Inc. ... automation and IT solutions for the life sciences industry, is pleased to announce the ... working out of the company’s Seabrook, New Hampshire office. In his new role, ...
(Date:6/5/2020)... ... , ... “Although we are disappointed to have to make this decision our ... public. We remain committed to creating a global platform to showcase the science, ... President of WMIS. , The abstract deadline for the virtual meeting ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... Va. (PRWEB) , ... July 08, 2020 , ... ... testing services and products, announces a significant expansion of laboratory operations through its ... collection for agencies implementing testing programs. , Bode-CARES provides a ...
(Date:7/10/2020)... ... 2020 , ... In most research using the zebrafish model, ... in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over the past ... the zebrafish model to investigate the causes of leukaemia and its relationship with ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now offering stem ... 200 million stem cells. Depending on the patient's condition, treatment may be offered IV, ... die having some form of Alzheimers dementia, and the incidence continues to increase as ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... date growth of 40% in 2020, despite many obstacles created as a result ... to increase revenue for its partnered medical practices and medical manufacturers by expanding ...
Breaking Biology Technology:
Cached News: